title: Metabolic syndrome.
abstract: Metabolic syndrome is a clustering of different risk factors that collectively increases the risk of developing cardiovascular disease and type 2 diabetes mellitus. The syndrome itself is associated with various metabolic abnormalities, including insulin resistance, non-alcoholic fatty liver disease, obstructive sleep apnoea, male hypogonadism and polycystic ovary syndrome. This review aims to discuss recent developments related to the syndrome, including the associated metabolic complications and goals for therapeutic strategies.
authors.affiliation: Department of Endocrinology, Changi General Hospital, 2 Simei Street 3, Singapore 529889. li_wei_cho@cgh.com.sg
authors.forename: L W
authors.initials: LW
authors.lastname: Cho
mesh_terms: D050197:Atherosclerosis / Q000150:complications; D002318:Cardiovascular Diseases / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis; D005260:Female; D006801:Humans; D007006:Hypogonadism / Q000150:complications; D007333:Insulin Resistance; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000175:diagnosis*; D009765:Obesity; D011085:Polycystic Ovary Syndrome / Q000150:complications; D012306:Risk; D012307:Risk Factors; D012891:Sleep Apnea Syndromes / Q000150:complications